Antioxidant Mechanisms and ROS-Related MicroRNAs in Cancer Stem Cells.
Ilaria DandoMarco CordaniElisa Dalla PozzaGiulia BiondaniMassimo DonadelliMarta PalmieriPublished in: Oxidative medicine and cellular longevity (2015)
Increasing evidence indicates that most of the tumors are sustained by a distinct population of cancer stem cells (CSCs), which are responsible for growth, metastasis, invasion, and recurrence. CSCs are typically characterized by self-renewal, the key biological process allowing continuous tumor proliferation, as well as by differentiation potential, which leads to the formation of the bulk of the tumor mass. CSCs have several advantages over the differentiated cancer cell populations, including the resistance to radio- and chemotherapy, and their gene-expression programs have been shown to correlate with poor clinical outcome, further supporting the relevance of stemness properties in cancer. The observation that CSCs possess enhanced mechanisms of protection from reactive oxygen species (ROS) induced stress and a different metabolism from the differentiated part of the tumor has paved the way to develop drugs targeting CSC specific signaling. In this review, we describe the role of ROS and of ROS-related microRNAs in the establishment and maintenance of self-renewal and differentiation capacities of CSCs.
Keyphrases
- cancer stem cells
- reactive oxygen species
- gene expression
- cell death
- dna damage
- dna methylation
- public health
- drug induced
- papillary thyroid
- squamous cell carcinoma
- signaling pathway
- stem cells
- high glucose
- locally advanced
- lymph node metastasis
- cancer therapy
- epithelial mesenchymal transition
- endothelial cells
- radiation therapy
- climate change
- rectal cancer